Satoshi Kobayashi

19PUBLICATIONS
45CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer geneticsPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Sep 25, 2025
Carbon-Ion Radiation Therapy Compared to Surgical Resection for Primary, Solitary, Potentially Resectable Hepatocellular Carcinoma.

Soichiro Morinaga, Shinnosuke Kawahara, Rei Kanemoto

|Sep 06, 2025
Combination chemotherapy for older patients with unresectable biliary tract cancer: a prospective observational study using propensity-score matched analysis (JON2104-B).

Satoshi Kobayashi, Kohei Nakachi, Kouji Yamamoto

|Jul 28, 2025
Modified Fluorouracil, Leucovorin, Irinotecan, and Oxaliplatin or S-1, Irinotecan, and Oxaliplatin Versus Nab-Paclitaxel + Gemcitabine in Metastatic or Recurrent Pancreatic Cancer (GENERATE, JCOG1611): A Randomized, Open-Label, Phase II/III Trial.

Akihiro Ohba, Masato Ozaka, Junki Mizusawa

|Jun 30, 2025
Peritoneum carcinomatosis as a favourable prognostic factor for treatment with nanoliposomal irinotecan and fluorouracil plus leucovorin in advanced pancreatic cancer.

Satoshi Kobayashi, Taito Fukushima, Shun Tezuka

|Aug 05, 2024
Trastuzumab Deruxtecan in Human Epidermal Growth Factor Receptor 2-Expressing Biliary Tract Cancer (HERB; NCCH1805): A Multicenter, Single-Arm, Phase II Trial.

Akihiro Ohba, Chigusa Morizane, Yasuyuki Kawamoto

|May 21, 2024
The correlation between immune-related adverse events and efficacy of immune checkpoint inhibitors.

Taito Fukushima, Satoshi Kobayashi, Makoto Ueno

Pageof 4

Frequent Collaborators

5 joint publications

Masafumi Ikeda

4 joint publications

Naohiro Okano

3 joint publications

Junji Furuse

2 joint publications

Yoshito Komatsu